Phase I trial of Thrombin-inhibitor VE-2851

Trial Profile

Phase I trial of Thrombin-inhibitor VE-2851

Phase of Trial: Phase I

Latest Information Update: 23 Nov 2017

At a glance

  • Drugs VE-2851 (Primary)
  • Indications Acute coronary syndromes; Stroke; Venous thrombosis
  • Focus Adverse reactions
  • Most Recent Events

    • 23 Nov 2017 New trial record
    • 15 Nov 2017 According to a Verseon media release, this trial is expected to start in 2018
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top